1999
Recruitment in AIDS Clinical Trials: Investigation of Sociodemographic and Psychosocial Factors Affecting Participation in Clinical Research
Ethier K, Rodriguez M, Fox-Tierney R, Martin C, Friedland G, Ickovics J. Recruitment in AIDS Clinical Trials: Investigation of Sociodemographic and Psychosocial Factors Affecting Participation in Clinical Research. AIDS And Behavior 1999, 3: 219-230. DOI: 10.1023/a:1025456527845.Peer-Reviewed Original ResearchTrial participantsIDU historyClinical trialsAIDS clinical trialsGroup of HIVTrial regimenMedical therapyPsychosocial factorsHIV therapeuticsClinical researchTrial resultsTrialsBehavioral factorsHIVSociodemographic dimensionsPrimary objectiveParticipantsNonparticipantsRegimenPatientsTherapyMSMSociodemographicsRecruitmentAdherence: a necessity for successful HIV combination therapy.
Chesney M, Ickovics J, Hecht F, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS 1999, 13 Suppl A: s271-8. PMID: 10885784.Peer-Reviewed Original ResearchConceptsCombination therapyHIV/AIDSHIV combination therapySuccessful treatment outcomeEmergence of resistancePatient adherenceClinical trialsDisease progressionLong-term benefitsRisk factorsHIV therapyTreatment outcomesTherapyAdherence researchResistant strainsHealth benefitsAdherenceIntervention programsVirus breakthroughAIDSIntervention effortsDifferent populationsValid methodFocused effortsHIV
1997
Issues Regarding Antiretroviral Treatment for Patients With HIV-1 Infection
Ickovics J, Chesney M. Issues Regarding Antiretroviral Treatment for Patients With HIV-1 Infection. JAMA 1997, 278: 1233-1234. PMID: 9333258, DOI: 10.1001/jama.1997.03550150037025.Peer-Reviewed Original ResearchConceptsAdherence behaviorPlasma human immunodeficiency virus (HIV) RNA levelsHuman immunodeficiency virus (HIV) RNA levelsDrug resistanceVirus RNA levelsHIV-1 infectionDrug regimenHIV diseaseAntiretroviral treatmentViral loadTreatment regimensCombination therapyPatients' willingnessDisease progressionCostly regimensConsensus statementMore pillsPatient healthRegimensRNA levelsAdherenceDearth of informationTherapyBrief periodNonadherence